Ageing and Chronic Diseases: Europe Rewards Human Technopole’s Research
The ERC has awarded HT a €2.5 million grant for a study investigating how lifestyle, biology and environmental exposures weaken the immune system over the course of life and increase vulnerability to disease in old age. This new knowledge will help develop models to predict long-term disease risk.
1 fully-funded PhD Position in the Jug Group through DADS
Are you passionate about AI, cutting-edge research, and making a real impact in biomedical science? The Jug Group at Human Technopole is thrilled to announce a new PhD opportunity as part of the prestigious PhD Programme in Data Analytics and Decision Sciences.
Preclinical Research Core Facility
Our institute’s Preclinical Research Facility is an advanced infrastructure dedicated to supporting the development of new therapies and biomedical technologies.
How thyroid hormones are transported into target cells
An international collaboration between Human Technopole and Erasmus Medical Centre researchers sheds light on the molecular mechanisms underlying the transport of thyroid hormones in human cells by monocarboxylate transporters (MCTs). The results of the research are published in Nature Communications.
Cancer, insomnia, ancient DNA: over 100 projects from Italian scientists at HT
Human Technopole has presented 102 research projects that were the first to benefit from the cutting-edge equipment of the National Facilities — the advanced technologies that the Institute makes available to external researchers from across Italy. The majority of studies focus on cancer and neurodegenerative diseases, accounting for 50% of the selected projects. The announcement was made this morning in Milan during “Open HT – The Open Day on Life Sciences”, an event designed to showcase Human Technopole’s achievements and outline future goals.
Previous page